Home › NCT04867395
A Multi-Phase Study Examining Hospital to Home Transitions for Children With Medical Complexity
Who can join
Ages 18 and older · All sexes · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria: Parents * English or Spanish-speaking * Parent or legal guardian and primary caregiver of child who has medical complexity (defined by significant chronic conditions in ≥2 body systems, progressive conditions associated with decreased life expectancy, dependence on technology for \>6 months \[e.g., respiratory equipment, central lines, feeding tubes\], or progressive/metastatic malignancies) who was admitted to the acute or intensive care units * The individual's child is ≤18 years old * The individual's child was discharged home or is expected be discharged home on ≥1 daily medication. * Willingness to be randomized to intervention group * Willingness and ability to participate in study procedures Exclusion Criteria: Parents * Caregiver \<18 years old * Poor visual acuity (\<20/50 corrected on Rosenbaum screener for in-person recruitment; by subject report for phone recruitment) * Self-reported hearing difficulty * Previously enrolled.
About the study
The overarching objective of this study is to make it easier for parents of children with medical complexity (CMC) to take care of their children after discharge home from the hospital and reduce the chance of post-hospitalization morbidity (meaning bad outcomes such as readmissions) after discharge. CMC, or those with multiple chronic conditions, progressive conditions, or technology dependence, are at high risk for post-hospitalization morbidity.
What is being tested
- HELPix Care Plan (behavioral)
Sponsor: NYU Langone Health · Participants: 282 · Started: Jul 23, 2021
Contact the study team
- Alexander F Glick, MD, MS · Phone: 212-263-8198
Official record on ClinicalTrials.gov — NCT04867395
Locations in the U.S.
| New York | NYU Langone Health, New York |
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.